. 2022 Mar 17;67(12):5693–5703. doi: 10.1007/s10620-022-07443-6

Table 2.

Prevalence of cytopenias in patients undergoing TIPS implantation

Nr. of patients	192 (100%)
Platelet count (G/L; median, IQR) Mild thrombocytopenia (G1: 100–149 G/L; n, %) Moderate/severe thrombocytopenia (G2/G3: ≤ 100 G/L; n, %)	131, 94–198 54, 28.1% 55, 28.7%
Hemoglobin (g/dL; µ ± SD) Mild anemia (G1: Hb: 10-m ≤ 13.5/f: ≤ 12.5 g/dL; n, %) Moderate/severe anemia (G2/G3: Hb < 10 g/dL; n, %)	10.8 ± 1.9 114, 59.4% 57, 29.7%
White blood cell count (G/L; median, IQR) Mild leukopenia (G1: 2–4 G/L; n, %) Moderate/severe leukopenia (G2/G3: < 2 G/L; n, %)	5.90, 4.37–7.65 34, 17.7% 3, 1.6%
Bicytopenia (n, %) Pancytopenia (n, %)	75, 39.1% 32, 16.7%

Nr. of patients

192 (100%)

Platelet count (G/L; median, IQR)

Mild thrombocytopenia (G1: 100–149 G/L; n, %)

Moderate/severe thrombocytopenia (G2/G3: ≤ 100 G/L; n, %)

131, 94–198

54, 28.1%

55, 28.7%

Hemoglobin (g/dL; µ ± SD)

Mild anemia (G1: Hb: 10-m ≤ 13.5/f: ≤ 12.5 g/dL; n, %)

Moderate/severe anemia (G2/G3: Hb < 10 g/dL; n, %)

10.8 ± 1.9

114, 59.4%

57, 29.7%

White blood cell count (G/L; median, IQR)

Mild leukopenia (G1: 2–4 G/L; n, %)

Moderate/severe leukopenia (G2/G3: < 2 G/L; n, %)

5.90, 4.37–7.65

34, 17.7%

3, 1.6%

Bicytopenia (n, %)

Pancytopenia (n, %)

75, 39.1%

32, 16.7%